Early and complete healing Durable safety and clinical performance Optimal scaffolding
The Pro-Healing DES
COMBO Plus is more than just a drug-eluting stent (DES). It is a combination of traditional DES components with the addition of a biological coating.
Sirolimus Release from a Bioabsorbable Polymer
The proprietary bioabsorbable polymer is coated on the abluminal side of the stent, allowing for directional drug release in 30 days and polymer absorption in 90 days.
Dual Helix Stent Design
1) Excellent radial strength 2) Large side branch access 3) Natural conformability
Unique 24-Month Neointimal Regression
A mechanistic study demonstrated that repeat OCT follow-up in the same patients showed a significant decrease in neointimal thickness and volume at 24-month compared to 9-month follow-up, indicative of neointimal maturation and stability.
Strut Level Neointimal Volume (mm3)
Strut Level Neointimal Thickness (mm)
Superior Healthy Tissue Coverage
Significantly greater and healthier tissue coverage at 1 year on 140 subjects under OCT analysis
Several trials including a randomized study dedicated to patients with Acute Coronary Syndrome (ACS) and registries with a sizeable ACS patient subset demonstrated consistently low event rates and short DAPT option of 3 months, if needed.
47% STEMI patients
REDUCE ACS 2 Year1
(n=1,460)
40% STEMI patients
REMEDEE ACS 1 Year2
(n=499)
10.9% with cardiogenic shock
NUHS AMI Registry 2 Years3
(n=260)
Several trials including a randomized study dedicated to patients with Acute Coronary Syndrome (ACS) and registries with a sizeable ACS patient subset demonstrated consistently low event rates and short DAPT option of 3 months, if needed.